Stockscreener 앱 받기
2.85
5.17%
0.14
왜 Abcellera Biologics Inc (ABCL) 주가가 하락하고 있습니까?
2024-12-13 거래 세션 동안 Abcellera Biologics Inc(ABCL) 주식이 5.59% 하락한 것을 확인했습니다. 이는 정상적인 변동성이나 다양한 내부 및 외부 요인에 의한 것일 수 있지만, 상황을 적극적으로 모니터링하고 있으며 최대한 빨리 적시에 업데이트를 제공하도록 하겠습니다!
2023-06-27:
Shares of AbCellera Biologics (ABCL) fell down 8.10% today. In fact, BACL stock trades down 88% off from its highs record at its initial public offering (IPO) in late 2020. AbCellera Biologics's revenue generation has gone down in 2023 because the emergency-use authorization from the U.S. Food and Drug Administration (FDA) on a partnered COVID-19 treatment, bentelovimab, expired in 2022.
https://ca.finance.yahoo.com/news/canadian-biotech-stocks-quietly-changing-224500362.html
2.88%
2.65%
자본화:
|
볼륨(24시간):